Cognitive Assessment: Multimodal Screening vs. Eye-Tracking
Two approaches to cognitive health. Different modalities, different clinical settings, different condition coverage.
NeuroTrack uses eye-tracking and digital cognitive tests to assess cognitive function, primarily in clinical trials and research settings. GIA® by Scienza Health screens for 46 conditions across cognitive, behavioral, and neurological categories using voice biomarkers and computer vision in post-acute, long-term, and workforce settings. Both serve clinical needs. The differences are in modality, condition coverage, clinical setting, and operational model.
How do they compare?
| Dimension | NeuroTrack | GIA™ |
|---|---|---|
| Primary modality | Eye-tracking + digital cognitive tests | Voice AI + Computer Vision + Speech Biomarkers |
| Condition categories | Cognitive assessment | Cognitive, behavioral, and neurological (46 conditions) |
| Clinical setting | Clinical trials, research | Post-acute care, long-term care, workforce |
| Staff required | Check vendor documentation | Zero during screening |
| Screening time | Check vendor documentation | Under 5 minutes |
| Regulatory status | Check vendor documentation | 510(k) cleared |
Where neurotrack falls short
A digital cognitive assessment company using eye-tracking technology and digital cognitive tests. Primary focus is clinical trials, research, and early cognitive impairment detection.
- Eye-tracking modality focuses on cognitive function assessment
- Primary market is clinical trials and research settings
- Check vendor documentation for condition coverage, regulatory status, and EHR integration
What GIA™ does differently
- 46 conditions across cognitive, behavioral, and neurological categories
- Voice biomarkers and computer vision analyzed simultaneously
- Under 5 minutes per screening. Results in 60 seconds
- Zero clinical staff required during screening
- 510(k) cleared. 19 peer-reviewed studies from Beth Israel, NIH, and MIT
- Results prepared for clinician review and submission to the EHR
- Deployed in post-acute care, long-term care, and workforce settings
NeuroTrack and GIA® by Scienza Health serve different clinical settings with different modalities. NeuroTrack focuses on cognitive assessment for research. GIA® screens across cognitive, behavioral, and neurological categories in care delivery settings where staffing constraints make traditional assessment impractical. The clinician always reviews and decides.
Common questions
What is the difference between cognitive assessment and multimodal clinical screening?
Cognitive assessment tools measure specific cognitive domains like memory, attention, and executive function. GIA® by Scienza Health goes beyond cognitive assessment to screen across behavioral and neurological categories simultaneously. 46 conditions from one conversation, including depression, PTSD, Parkinson’s, and tardive dyskinesia. Results prepared for clinician review.
Which tool is better for post-acute care facilities?
Post-acute care facilities face a 450,000-nurse shortage and cannot staff traditional one-on-one assessments consistently. GIA® by Scienza Health requires zero clinical staff during the screening conversation and screens for 46 conditions in under 5 minutes. She integrates with PointClickCare, Epic, Cerner, and MatrixCare. 510(k) cleared.
Does GIA® replace cognitive assessment tools?
GIA® by Scienza Health screens across a broader range of conditions than any single cognitive assessment tool. She is not a replacement for clinical judgment. Every screening result is prepared for clinician review. The clinician reviews, decides what action to take, and submits to the EHR. GIA® assists clinical judgment. She never replaces it.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.